New Drug Application (NDA) Submissions 505(b)(1) Or 505(b)(2)
There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough...
Source: clinicalleader.com
Reference Listed Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Reference Listed Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Reference Listed Drug Today - Breaking & Trending Today
Stocks in news: Apollo Tyres, Paytm, BHEL, Sun Pharma, Grasim, Ircon and PI Industries
Sun Pharma, Power Grid, Grasim, Max Healthcare, India Bank, Nykaa, Petronet LNG, Metro Brands, Gland Pharma and Paytm are among the companies that will announced Q4 results later today.
Source: businesstoday.in
Indoco Remedies shares gain on final USFDA approval for Pregabalin capsules
The share touched a 52-week high of Rs 416.95 and a 52-week low of Rs 308.80 on January 1, 2024, and October 26, 2023, respectively.
Source: moneycontrol.com
Strides receives USFDA approval for Sucralfate oral suspension; stocks move up
Strides Pharma gains 0.76% as USFDA approves Sucralfate Oral Suspension, expanding product portfolio and market reach.
Source: thehindubusinessline.com
USFDA Grants Approval To Strides Pharma For Generic GERD Treatment Formulation
Moreover, Strides Pharma’s ambitious plans to launch approximately 60 new products in the US over the next three years further underscore its commitment to portfolio diversification and expansion. This forward-looking approach aligns with the company’s overarching objective of bolstering its market presence and addressing evolving healthcare needs. - Newsx
Source: newsx.com